Healthcare Economics & Policy

Critical shortages of imaging equipment and qualified radiologists left an estimated 56,000 angina patients without access to potentially lifesaving computed tomography (CT) scans last year, the Royal College of Radiologists and British Society of Cardiovascular Imaging announced Nov. 8.

Climbing rates of violent crime could trigger blood pressure (BP) spikes within nearby communities—particularly among individuals living in what are considered “safe” neighborhoods—according to a study of 50,000 adults living in Chicago.

While many Americans were fixated on the Congressional races during the Nov. 6 midterm elections, the American Heart Association and CEO Nancy Brown kept an eye on ballot measures with implications for cardiovascular health.

A clinical and economic analysis of PCSK9 inhibitors in Canadian patients with atherosclerotic cardiovascular disease (ASCVD) is solidifying physician concerns that the lipid-lowering drugs might be too inaccessible—or too pricey—to benefit the average heart patient.

Mandatory CPR training in high school may contribute to higher rates of bystander intervention and improved survival following out-of-hospital cardiac arrest (OHCA), according to a registry study slated to be presented Nov. 11 at the American Heart Association’s Resuscitation Science Symposium in Chicago.

Biopharmaceutical company Amarin announced top-line results for its purified eicosapentaenoic acid (EPA) product in September, hailing the 25 percent risk reduction in a composite of cardiovascular outcomes associated with icosapent ethyl (Vascepa). But critics who commented on the results to Kaiser Health News worried the excitement over the trial is premature.

Physicians successfully reversed the bleeding risk-treatment paradox in percutaneous coronary intervention (PCI) by prioritizing risk-concordant use of bleeding avoidance strategies like bivalirudin, radial access and vascular closure devices, according to a report published Oct. 31 in the Journal of the American Heart Association.

Following President Trump’s recent comments about rescinding birthright citizenship in the U.S., one pediatric cardiologist is speaking out about his own history and career at Vanderbilt—a career, he says, that wouldn’t be possible without the 14th amendment.

A London, Kentucky, cardiologist was sentenced to 42 months in federal prison Oct. 31 after reportedly implanting “dozens” of unnecessary pacemakers and defrauding both his patients and their insurers, U.S. Attorney Robert M. Duncan, Jr., has announced.

Hospitals offering transcatheter aortic valve replacement (TAVR) tend to produce the best survival outcomes when both TAVR and surgical AVR (SAVR) caseloads remain high, according to a study published Oct. 31 in JAMA Cardiology.

Another drug with the potential to lower cholesterol beyond maximally tolerated statin therapy is preparing to enter the marketplace, STAT reported on Oct. 28.

The National Institutes of Health (NIH) is pausing a taxpayer-funded, $63 million trial of cardiac stems cells over questions about the basis for the research.